Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Mestinon
Active Ingredient: Pyridostigmine bromide 61.2mg equivalent to 60mg Pyridostigmine
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Valeant Canada Limited, Montreal, Quebec, Canada
Note: This consent is valid for two years from 3 November 2007.
Dated this 26th day of October 2007.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).